Bank of Montreal
VRTX icon

Bank of Montreal’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of Montreal’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,600
Closed -$2.32M – 5079
2019
Q1 		$2.32M Buy
+12,600
New +$2.33M ﹤0.01% 1586

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of Montreal's VRTX Position: Q2 2026 in Review

Bank of Montreal increased its Vertex Pharmaceuticals (VRTX) stake by 9.5% in Q2 2026, buying an estimated $16.4M and bringing the position to 427,448 shares worth $212M. The position accounts for 0.07% of the portfolio, ranked #225.

Bank of Montreal first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $258M in Q3 2024. 1,247 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Bank of Montreal held 427,448 shares of Vertex Pharmaceuticals worth $212M as of Q2 2026.
  • Bank of Montreal bought 36,972 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16.4M.
  • Vertex Pharmaceuticals made up 0.07% of Bank of Montreal's portfolio in Q2 2026, its #225 holding.
  • Bank of Montreal first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Vertex Pharmaceuticals position peaked at $258M in Q3 2024.
  • 1,247 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.